Fractional Flow Reserve Market - Industry-Specific Opportunities and Trends Affecting the Growth
2022-06-09 13:43:09 UTC | Healthcare & Pharmaceuticals
MarketsandMarkets™ Research Report's View on Revenue Impact?
The fractional flow reserve market is projected to reach USD 1,081.8 million by 2024 from USD 516 million in 2019, at a CAGR of 16.0% during the forecast period.
Factors Responsible for Growth and In-Depth Analysis?
Rising geriatric population and the subsequent growth in the prevalence of CVD;
Over the years, there has been a significant increase in the geriatric population across the globe. According to the UN World Population Ageing Report 2017, the global geriatric population (aged 60 years and above) is expected to reach 2.1 billion by 2050 from 962 million in 2017.
As this population segment is highly susceptible to CVD and other target diseases, the demand for advanced diagnostic and treatment options is expected to increase in the coming years. Changing lifestyle, smoking, hypertension, high blood cholesterol levels, physical inactivity, high BMI, and high blood sugar levels are the leading risk factors for heart disease and stroke. With the rising prevalence of CVD, the number of related diagnostic and treatment procedures is expected to increase significantly across the globe in the coming years. In this scenario, the demand for fractional flow reserve is likely to increase as it provides various benefits, such as assessing if the stenosis is required, which in turn helps in avoiding surgeries (in cases where stenosis is not needed).
Leading Key Players and Analysis:
Abbott (US), Boston Scientific (US), ACIST Medical Systems (US), Koninklijke Philips N.V. (Netherlands), Opsens, Inc. (Canada), HeartFlow, Inc. (US), Siemens Healthineers (Germany), Pie Medical Imaging (Netherlands), CathWorks (Israel), and Medis Medical Imaging Systems BV (Netherlands)
Geographical Analysis in Detailed?
Asia Pacific to register the highest CAGR during the forecast period, Market growth in the Asia Pacific is mainly driven by the rapid growth in the geriatric population and the increasing prevalence of cardiovascular diseases.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=257837023
The invasive monitoring segment to account for the largest market share during the forecast period;
Based on technology, the fractional flow reserve market is segmented into invasive and non-invasive monitoring. The invasive monitoring segment accounted for the largest share of the market in 2018 and will continue to do so during the forecast period. Invasive FFR monitoring is considered the gold standard for determining the hemodynamic impact of coronary lesions. This technology utilizes pressure guidewires and monitoring systems for the measurement of fractional flow reserve. The pressure guidewire measures the flow and pressure of the blood before and after the blockage to produce a ratio.
The single-vessel diseases segment will dominate the market during the forecast period;
Based on application, the fractional flow reserve market is segmented into single-vessel diseases and multi-vessel diseases. In 2018, the single-vessel disease segment accounted for the larger share of the fractional flow reserve market. The large share of this segment can be attributed to the high prevalence of single-vessel coronary artery disease.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=257837023